Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs HRB✓SelectedUSD · HRBGSK vs HRB performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs HRB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+44.4%
HRB return
+140.6%
Excess return
-96.3%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioHRBExcessAlpha
1D+0.5%-1.4%+1.9%+0.6%
7D+1.1%-5.1%+6.2%+1.4%
30D+6.3%+8.7%-2.3%+5.8%
3M+1.8%-5.4%+7.2%+2.0%
6M+1.7%+41.6%-39.9%-0.3%
YTD+6.5%+18.7%-12.1%+5.9%
1Y+9.5%+16.4%-7.0%+9.0%
3Y+65.3%+22.0%+43.3%+64.4%
All+44.4%+140.6%-96.3%+40.0%

Cumulative growth

Daily Returns

Daily percentage return beside HRB.

Daily Out/Under-Performance

Portfolio return minus HRB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × HRB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded HRB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling